Renerval Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Renerval Therapeutics General Information

Description

Developer of cell therapy technologies designed to provide regenerative medicine solutions for blood and oncology sectors. The company offers regenerated platelets, artificial red blood cells, car-ink cell therapies, universal cell therapy platforms, blood system cell preparation platforms, and drug delivery technologies, thereby enabling healthcare providers to treat tumors, neurological diseases, and blood disorders using induced pluripotent stem cell and gene editing technologies.

Contact Information

Formerly Known As
Heluo Xintu Biotechnology (Nanjing)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building 7
  • Number 388 Galileo Road, Pudong New Area
  • Shanghai, 200100
  • China
+86 135
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1st Floor, Building 7
  • Number 388 Galileo Road, Pudong New Area
  • Shanghai, 200100
  • China
+86 135

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renerval Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 03-Sep-2026 Completed Generating Revenue
4. Later Stage VC (Series A1) 07-Aug-2026 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Oct-2024 Completed Clinical Trials - General
2. Early Stage VC 02-Feb-2023 Completed Clinical Trials - General
1. Seed Round 25-Apr-2022 Completed Startup
To view Renerval Therapeutics’s complete valuation and funding history, request access »

Renerval Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Minhang Government Government Minority
Shenzhen Yifeng Investment Management Enterprise Venture Capital Minority
Furong Capital Growth/Expansion Minority
Shaaxi Shantou Capital Government Minority
Shunwei Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Renerval Therapeutics FAQs

  • When was Renerval Therapeutics founded?

    Renerval Therapeutics was founded in 2021.

  • Where is Renerval Therapeutics headquartered?

    Renerval Therapeutics is headquartered in Shanghai, China.

  • What industry is Renerval Therapeutics in?

    Renerval Therapeutics’s primary industry is Biotechnology.

  • Is Renerval Therapeutics a private or public company?

    Renerval Therapeutics is a Private company.

  • What is Renerval Therapeutics’s current revenue?

    The current revenue for Renerval Therapeutics is .

  • Who are Renerval Therapeutics’s investors?

    Shanghai Minhang Government, Shenzhen Yifeng Investment Management Enterprise, Furong Capital, Shaaxi Shantou Capital, and Shunwei Capital are 5 of 6 investors who have invested in Renerval Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process